George Golumbeski

Companies

• Acumen Pharmaceuticals, Inc.Board member Nov 10, 2025 to now¹
• Mural Oncology plcBoard member Jul 31, 2024 to now²
• Shattuck Labs, Inc.Board member Oct 8, 2020 to now³
• Sage Therapeutics, Inc.Board member Jan 24, 2019 to now⁴
• Corbus PharmaceuticalsBoard member Jul 8, 2020 to Jul 8, 2020⁵
• ENANTA PHARMACEUTICALS INCBoard member Feb 11, 2014 to Feb 28, 2020⁶
• Acceleron PharmaBoard member Sep 18, 2013 to Sep 18, 2013⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SLShattuck Labs, Inc. STTK54,613 shares⁸$298.2K at $5.46Apr 26, 2022
• APAcumen Pharmaceuticals, Inc. ABOS35,500 shares⁹$62.1K at $1.75Jun 3, 2026
• STSage Therapeutics, Inc.0 shares¹⁰Jul 31, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 3, 2026Granted 35,500 shares of Acumen Pharmaceuticals, Inc.⁹
• Jul 31, 2025U 8,000 shares of Sage Therapeutics, Inc.¹⁰
• May 5, 2022Bought 8,000 shares at $31.45 of Sage Therapeutics, Inc.¹¹
• Apr 26, 2022Bought 28,330 shares at $3.63 of Shattuck Labs, Inc.⁸
• Apr 22, 2022Bought 234 shares at $3.67 of Shattuck Labs, Inc.¹²
• Apr 21, 2022Bought 26,049 shares at $3.69 of Shattuck Labs, Inc.¹²